Valuation: LifeMD, Inc.

Market Cap 141M 125M 118M 107M 201M 13.55B 202M 1.41B 545M 6.92B 530M 519M 22.27B P/E 2026 *
-5.55x
P/E 2027 * -31.5x
Enterprise Value 141M 125M 118M 107M 201M 13.55B 202M 1.41B 545M 6.92B 530M 519M 22.27B EV / Sales 2026 *
0.68x
EV / Sales 2027 * 0.58x
Free-Float
84.02%
Yield 2026 *
-
Yield 2027 * -
1 day-1.71%
1 week-12.73%
Current month-6.80%
1 month-8.28%
3 months-31.43%
6 months-22.58%
Current year-15.54%
1 week 2.85
Extreme 2.85
3.06
1 month 2.85
Extreme 2.85
3.5
Current year 2.56
Extreme 2.56
5.38
1 year 2.56
Extreme 2.56
7.32
3 years 2.56
Extreme 2.56
15.84
5 years 1.14
Extreme 1.14
15.84
10 years 0.42
Extreme 0.421
33.02
Manager TitleAgeSince
Chief Executive Officer 39 2025-07-31
Director of Finance/CFO 57 2026-03-15
Chief Tech/Sci/R&D Officer - 2026-05-31
Director TitleAgeSince
Chairman 65 -
Director/Board Member 75 2014-09-03
Chairman 43 2019-06-10
Date Insider Type Main position Quantity % Market Cap. Importance
8/11/26 Free

Director

35,000 0.0724%
8/11/26 Free

Director

35,000 0.0724%
8/11/26 Free

Director

35,000 0.0724%
Change 5-day change 1-year change 3-year change Capi.($)
-1.71%-12.73%-55.28%-53.92% 141M
-0.50%+6.77%-4.92%+36.92% 45.33B
+0.99%-1.09%-45.73%+101.75% 11.89B
+1.04%+2.83%-5.65%+128.08% 5.57B
-0.18%-0.68%+44.43% - 4.34B
+3.42%-11.68% - - 1.91B
+1.30%+3.44%+13.09%-23.82% 1.54B
-3.50%-6.39%+5.16%+131.03% 962M
-0.26%-5.72%+29.73%+34.80% 853M
+2.33%+2.03%-26.42%-47.92% 791M
Average +0.29%-2.20%-5.07%+38.37% 7.33B
Weighted average by Cap. +0.01%+3.76%-8.17%+54.71%

Financials

2026 *2027 *
Net sales 208M 183M 173M 157M 295M 19.93B 298M 2.08B 802M 10.17B 780M 763M 32.74B 245M 216M 205M 186M 348M 23.53B 352M 2.46B 947M 12.02B 921M 901M 38.67B
Net income -24.81M -21.89M -20.71M -18.78M -35.22M -2.38B -35.56M -248M -95.76M -1.22B -93.15M -91.12M -3.91B -4.54M -4.01M -3.79M -3.44M -6.45M -436M -6.52M -45.52M -17.54M -223M -17.07M -16.69M -717M
Net Debt - -
Logo LifeMD, Inc.
LifeMD, Inc. is a patient-centric, direct-to-patient healthcare company. The Company is engaged in providing patients access to virtual medical care and pharmacy services. Its telehealth platform helps patients access licensed providers for diagnoses, virtual care, and prescription medications, often delivered on a recurring basis and sells over the counter (OTC) products. Its products are available on a subscription or membership basis, where a patient can subscribe to receive regular shipments of prescribed medications or products. The Company's men's brand, RexMD, offers access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation and hair loss. Its vertically integrated care model combines technology, affiliated clinical services, pharmacy infrastructure, and artificial intelligence (AI)-enabled operational systems to deliver longitudinal care.
Employees
350
Date Price Change Volume
26-09-29 US$2.880 -1.71% 809,491
26-09-28 US$2.930 -1.35% 602,524
26-09-25 US$2.970 +2.06% 767,808
26-09-24 US$2.910 -4.59% 859,017
26-09-23 US$3.050 -7.58% 816,599
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.880USD
Average target price
8.125USD
Spread / Average Target
+182.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFMD Stock